Yudong Li Selected Research

Biomarkers (Surrogate Marker)

1/2023	Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors.
11/2017	Long non-coding RNA CRALA is associated with poor response to chemotherapy in primary breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yudong Li Research Topics

Disease

16	Neoplasms (Cancer) 04/2024 - 01/2013
10	Breast Neoplasms (Breast Cancer) 02/2024 - 11/2017
2	Foreign Bodies (Foreign Body) 04/2024 - 12/2023
2	Squamous Cell Carcinoma of Head and Neck 03/2023 - 01/2022
1	Neoplasm Metastasis (Metastasis) 04/2024
1	Cardiotoxicity 02/2024
1	Inflammation (Inflammations) 01/2023
1	Anemia 05/2022
1	Lymphoid Leukemia 01/2022
1	Chronic Renal Insufficiency 09/2021
1	Long Term Adverse Effects 06/2021
1	Papillary Thyroid Cancer 01/2021
1	Triple Negative Breast Neoplasms 03/2020
1	Wounds and Injuries (Trauma) 02/2019
1	Burns 02/2019
1	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2018
1	Infections 07/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2010
1	Birth Weight (Birth Weights) 10/2004

Drug/Important Bio-Agent (IBA)

5	Long Noncoding RNAIBA 10/2023 - 11/2017
4	Proteins (Proteins, Gene)FDA Link 10/2023 - 11/2020
2	Cyclin D1IBA 01/2023 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2017
2	Tamoxifen FDA LinkGeneric 11/2020 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2020 - 01/2018
2	Estrogen ReceptorsIBA 01/2020 - 01/2020
1	Peptides (Polypeptides)IBA 04/2024
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2024
1	IntegrinsIBA 04/2024
1	1- cyclohexyl- 2- (5H- imidazo(5,1- a)isoindol- 5- yl)ethanolIBA 04/2024
1	PorphyrinsIBA 04/2024
1	Biocompatible Materials (Biomaterials)IBA 04/2024
1	1-dodecylpyridoxal (PLD)IBA 02/2024
1	pertuzumabIBA 02/2024
1	liposomal doxorubicin (Doxil)FDA Link 02/2024
1	Trastuzumab (Herceptin)FDA Link 02/2024
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024
1	Epidermal Growth Factor (EGF)IBA 02/2024
1	AnthracyclinesIBA 02/2024
1	Taxoids (Taxanes)IBA 02/2024
1	SolutionsIBA 12/2023
1	SaltsIBA 12/2023
1	CyclinsIBA 10/2023
1	MTOR InhibitorsIBA 01/2023
1	thiamine triphosphorate (TTP)IBA 01/2023
1	OligonucleotidesIBA 01/2023
1	palbociclibIBA 01/2023
1	CarbonIBA 05/2022
1	Erythropoietin FDA Link 05/2022
1	A-factor (Streptomyces)IBA 01/2022
1	Calcium-Binding ProteinsIBA 01/2022
1	PotassiumIBA 01/2022
1	LigandsIBA 01/2022
1	Karyopherins (Importin)IBA 01/2022
1	Diacylglycerol KinaseIBA 01/2022
1	Caffeine (No Doz)FDA LinkGeneric 09/2021
1	Coffee FDA Link 09/2021
1	HydrocarbonsIBA 06/2021
1	Petroleum (Crude Oil)IBA 06/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	Circular RNAIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 11/2020
1	Carrier Proteins (Binding Protein)IBA 03/2020
1	Circulating Tumor DNAIBA 01/2020
1	VaccinesIBA 07/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2013
1	Neuroprotective AgentsIBA 09/2011
1	Peroxynitrous Acid (Peroxynitrite)IBA 09/2011
1	myricetinIBA 09/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2004

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2024 - 06/2010
6	Therapeutics 01/2024 - 07/2018
3	Neoadjuvant Therapy 02/2024 - 06/2018
2	Immunotherapy 04/2024 - 01/2024
2	Radiotherapy 01/2022 - 01/2018
1	Photochemotherapy (Photodynamic Therapy) 04/2024
1	Segmental Mastectomy (Lumpectomy) 02/2024
1	Combination Drug Therapy (Combination Chemotherapy) 02/2024
1	Neck Dissection (Radical Neck Dissection) 01/2022
1	Lasers (Laser) 02/2019
1	Mastectomy (Mammectomy) 08/2018
1	Prophylactic Mastectomy 08/2018
1	Tissue Transplantation 06/2010